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Detection of Carcinogen-DNA Adducts
in Human Fetal Tissues by the
32P-Postlabeling Procedure
by Claus Hansen,' Inger Asmussen,2 and Herman
Autrup3
Tobacco smokecontainsanumberofgenotoxic compoundsthataremetabolizedtotheirbiologically activeformsthat
subsequently reactwithcellularDNAtoformcovalently boundcarcinogen-DNA adducts. Severalanalytical procedures
have been developed todetecttheseadductsinhumantissues. UsingthenucleaseP1-enhanced 32P-postlabeling procedure
forbulky adducts, wehavedetectedatleast24adducts inDNAisolatedfromplacentaandumbilical cordDNA. Adducts
weredetectedinbothsmokersandnonsmokers, buttherelative adductlevel(RAL) wassignificantly higherinsmokers
(42.8, 8cases) than innonsmokers (19.7, 11 cases). Theoriginofthe adductsin nonsmokersremains unknown. The ad-
ductlevels inartery DNAweresignificantly lowerthanintheveinandtheplacenta, andapairednonparametric analysis
showedasignificantassociationbetweentheadductlevelsinthethreetissues. Ourresultsshowamaternal transferofcar-
cinogenspresentincigarettesmoketofetaltissuesandshowthatthetissuescanmetabolizethecarcinogenstotheirDNA
bindingmetabolites. Thepresenceofadductsinfetaltissues may be indicative ofgenomic damage andmay predispose
the individual for the development ofa serious disease iter inlife.
Introduction
Epidemiological andlaboratory investigations haveshownthat
environmental carcinogens, including the ones found in tobac-
co smoke, play an important role intheetiology ofcancer [e.g.,
cancerofthelung, larynx, oral cavity, andbladder(1)]. Recent-
ly, it has beenproposed thatchemical carcinogens may also be
involved in thedevelopmentofvarious forms ofcardiovascular
disease (2,3). In addition, smoking tobacco products during
pregnancy is associated with an increased risk to the unborn
child, resulting in preterm delivery, decreased birth weight,
stillbirth, and a number of serious congenital malformations
(4-6).
Chemical carcinogens aremetabolized in anumberofhuman
tissuesandcells(7,8), andsmokingrelatedcarcinogen-DNA ad-
ducts have been detected in human tissue (9-11). The adduct
levels in lung tissue correlate with the number of cigarettes
smoked, and these adducts are retained for a relatively long
periodafter cessation ofsmoking (9). Exposure tochemical car-
cinogens during pregnancy leads to in vivo formation of
carcinogen-DNA adducts not only in the placenta, but also
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in the lungs and livers ofaborted fetuses (5,12,13).
WereportthatcovalentlyboundDNAadducts, asassessedby
32P-postlabeling, are present in the placenta as well as in um-
bilicalcordvasculatureobtained fromotherwisehealthy smok-
ing and nonsmoking donors. Adduct levels were found to be
significantly higher in smokers as compared to nonsmokers.
Maternal adductlevelsweresignificantlyhigherthanfetal levels,
andmarginally significantdifferences wereobtainedbetweenad-
duct levels in the three tissues when smokers and nonsmokers
were compared.
Materials and Methods
Donors. Nineteencompletelyhealthy womenwereselected,
all ofwhomhadhad anuncomplicatedpregnancy anddelivery
and who hadgiven birth to healthy, full-term children without
any abnormalities andwith anApgar scoreof10/10. Priortothe
collection, allthe womengaveinformedconsentaccordingtothe
Helsinki II declaration. According to the questionnaire, 11 of
these women were nonsmokers, including 3 who had ceased
smoking morethanayearbeforepregnancy. Thesmokinggroup
comprisedeightwomen, ofwhomtwosaidthattheysmokedless
than 10cigarettes daily.
Isolation ofTissuesandDNA. Tissue blocks were obtained
fromplacentaandumbilical cordwithin4hrafterdelivery, and
cordartery andvein werecarefully dissected. Allsamples were
codedbeforeDNAisolationandpostlabeling inordertoperform
a blind analysis of the samples. DNA was isolated from the
tissuesessentially asdescribed(4). Theendotheliumoftheum-HANSENETAL.
bilical cord vessels was not removed from the basement mem-
branebeforeDNA isolation. Theconcentrationandqualityofthe
DNA were estimated by spectrophotometry at260and280 nm.
Following quantification, purified DNA was frozen and stored
at -20°C until use.
32P-PostlabelingAssay. DNA wasenzymaticallydegraded to
deoxynucleoside 3'-monophosphates by incubation with amix-
ture of micrococcal nuclease (2U/IL) and spleen phospho-
diesterase (2 Rg/jzL) for 16hr(15). Nuclease P1(0.3jtg/pgDNA)
was used to remove nonmodified nucleosides fromthe suspen-
sion beforepostlabeling (16). Thecarcinogen-modified nucleo-
sides were transformed to their 5 '-32P-labeled deoxynucleotide
3 ',5 '-bisphosphateby T4polynucleotidekinase(3 U/4 ugDNA)
and freshly made [_y-32P]ATP (75 liCi/4 yg DNA) (17). The
samples wereincubated for30min at37°C with potato apyrase
(10mU/pg DNA) to remove unreacted ['y-32P]ATP. The samples
were then separated on PEI-cellulose TLC plates (10 x 20cm).
The plate wasautoradiographed andthe spots werequantified
by Cerenkovcounting. Relativeadductlevel (RAL)values were
calculated as described (16) and expressed as number ofbase
modifications per 109 nucleotides.
StatisticalMethods. For most statistical analyses, anunpaired,
one-tailed Student's t-test wasapplied, using a significance level
of 5 %. For comparison ofadduct levels between placenta, um-
bilical cord vein, and artery, Duncan'smultiple rank test wasused.
Results
Identification ofCarcinogen-DNA Adducts
Covalently bound carcinogen-DNA adducts weredetected in
tissues from both smokers and nonsmokers. A total of24 dif-
ferent adducts wasdetected. Nodefinitivecorrelation was found
between specific adduct spots and smoking status. Because the
amountofradioactivity in some areas oftheautoradiographs was
very high, we wereunable to separatethese areas intoindividual
spots. These were, therefore, counted as one single spot and
given a spot number of their own, even though spot numbers
already wereassigned to areasofthechromatogramoccupiedby
the composite spot. This may have led to discrepancies when
specific smoking-related spots were evaluated. The presence of
covalently bound DNA adducts in onetissue did not necessari-
ly correlate with the presence ofthe same adduct in the other
tissues from the same donor.
Relative Adduct Levels
Large interindividual variation was observed in total adduct
levels (RAL value) in tissues from both smokers and non-
smokers. Smokers had higher adduct levels as compared to
nonsmokers. RALvaluesinsmokersregardless oftissue, com-
pared with nonsmokers (Table 1) were significantly different
(p = 0.021) using an unpaired Student's t-test, and the adduct
level inmaternal tissue wassignificandyhigher (p = 0.030)than
in fetal tissue. No statistical difference wasobservedwhentotal
fetal adductlevelsbetween smokersandnonsmokers were com-
pared (p = 0.089).
The mean value of RAL in placenta from smokers and
nonsmokers was equivalent to that in the corresponding um-
Table 1. Meanadduct levelsinhuman placentaand umbilicalcordvessels.
RAL value x
Smoking status Tissue 109 nucleotidesa Sample size p-Valueb
Nonsmoker Total"' 19.7 ± 4.2 29
0.021
Smoker Total,' 42.8 ± 11.5 22
Both Fetal 21.8 + 6.1 33
0.030
Both Maternald 44.0 ± 11.0 18
Nonsmoker Fetal 14.7 ± 5.1 19
0.089
Smoker Fetal 31.4 + 12.4 14
Both Placenta 44.0 + 11.0 18 Ae
Both Vein 30.1 + 4.9 16 A,B`
Both Artery 14.0 + 11.2 17 Be
Nonsmoker Placenta 29.2 + 6.8 10
0.067
Smoker Placenta 62.6 ± 22.3 8
Nonsmoker Vein 7.3 + 2.3 10
0.054
Smoker Vein 23.5 ± 11.0 7
Nonsmoker Artery 22.9 + 10.0 9
0.244
Smoker Artery 39.4 ± 23.0 7
RAL, relative adduct level.
'RAL value ± SE ofthe mean.
bUnpaired, one-tailed Student's t-test except where noted.
CPlacenta, vein, and artery tissues were combined.
dMaternal tissue is defined as placenta, athough this is a mixed tissue con-
sisting ofboth maternal and fetal tissues.
CStatistical analysis was done with Duncan'smultiple range test.
bilicalcordartery, whereasthelevel inumbilical cordveinwas
significantly lowerthan the mean RAL value in placenta. Fur-
thermore, comparisonbetweensmoking statusofthemotherand
mean RAL values in placenta, umbilical cord vein, and artery
showed that the levels tended to be higher in smokers than in
nonsmokers. This observation, however, was only marginally
significant for placenta and vein (p = 0.067 and p = 0.059,
respectively).
Discussion
Smoking-related DNA adducts have been demonstrated in
placental tissues (5,12,18). Using the 32P-postlabeling technique,
carcinogen-DNA adducts havebeendetected inumbilical cord
veinandartery inadditiontoplacentafrombothnonsmokingand
smokingwomen. Theadducts innonsmokers mustbeascribed
tochemicalcompoundspresentinthegeneralenvironment. The
tissuedonorslivedinahighlypopulatedareaofCopenhagen. An
alternativeexplanation forthesebackground spotsinnonsmok-
ing donors could be that these adducts originate from intrinsic
factors(19)orarerelatedtoageordietaryproducts(20). Third,
thepresenceofbackground adductspots innonsmokers maybe
indicativeofpassivesmoking, butinformationonexposuretoen-
vironmentaltobacco smokewas notobtained. Theobservation
thatcovalentlyboundDNAadductswerepresentnotonlyinthe
placentabutalso in umbilical cord vein and artery, two tissues
ofsolely fetalorigin, indicates thatthe fetus istransplacentally
exposedtogenotoxiccompounds found inthegeneral environ-
ment. We have not been able to show any correlation between
distinct adduct spots and maternal smoking, similar to other
investigators.
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Meanadductlevels intissues fromsmokersweresignificantly
higher than in tissues from nonsmokers. Large interindividual
variation intherelativeadductlevel wasobserved withinboththe
smoker and nonsmoker group. For smokers, the number of
cigarettes smoked perday may have an effect as seen in human
lung (10). More than a 70-fold variation in the level of aryl
hydrocarbon hydroxylase activity was observed in placental
tissues. This combined with differences in DNA repair capa-
bilities could influence adduct levels (9).
The mean adduct level in maternal tissues was significantly
higher than the level in fetal tissue. Toreach fetal tissues, com-
pounds mustdiffuseacrosstheplacentalbarrier, whichmay re-
tain several compounds due to differences in hydrophobicity.
Comparing the mean nonsmoking maternal adduct level with
mean nonsmoking fetal tissue shows that there is a marginally
significanthigher level inmaternaltissue, whereasthedifference
intissues from smokers wasobliterated. This mayindicatethat
theplacentaofnonsmokingdonorsmetabolizestherelatively low
levels ofchemical carcinogens present, turningthem into DNA
binding forms, which mostly react with placental DNA. In
smokers, however, the amountofchemical substances exceeds
themetabolizingcapacityoftheplacenta, andprocarcinogens or
metabolites aretransferredtothefetusresulting inadduct levels
comparable to thatofmaternal tissue.
Theobservationthatthemeanadductlevelinplacentaandfetal
umbilicalcordveinDNAismarginally increasedinsmokers is
aninterestingfinding, becausethissubstantiatesthattransplacen-
tal exposure to chemical carcinogens occurs in humans. How-
ever, no statistical difference between average adduct levels in
umbilical cord artery from smokers and nonsmokers was
observed, although the trend indicates that such a correlation
might exist.
Severalanimal studieshaveshownthattransplacentalexposure
tochemicalcarcinogens mayleadtoanincreased riskofdevelop-
ing cancer later in life. The finding that adducts are formed in
utero in otherwise normal human fetuses, notonly as a conse-
quenceofmaternal smoking, butalsoasaconsequenceofback-
ground exposures to genotoxic compounds in theenvironment
isofconcernbecausetheDNAdamagemay resultinan initiated
cancer cell.
Conclusions
Itcanbeconcludedthatcarcinogen-DNA adductsareformed
inhumanplacentaandinumbilicalcordarteryandveinasacon-
sequence oftransplacental exposure to genotoxic compounds.
The formation ofadducts in these tissues seems to correlate to
maternal smokingduringpregnancy, althoughadducts areform-
edtoacertainextent in nonsmokers. The latter isprobablydue
toenvironmental exposuresfromothersources. Adductlevelsin
tissues obtained from smokers were marginally higher than in
tissues fromnonsmokers. Fetalmetabolismseemstoplaya role
in the transformation ofgenotoxic compounds into reactive
metabolitesbecauseitwasobservedthatthelevelofadductsinum-
bilicalcordarterywasofthesamemagnitudeasthatfoundinthe
placenta, whereasmeanadductlevelsintheumbilicalcordvein
weresignificantly lowerthaninplacenta.
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